Sign in
4

Changes in Ownership

SELLAS Life Sciences Group, Inc. Filed Acc 0001394548-17-000026

Director acquired 9,161 shares (grant or award)

From the SEC's structured data for this filing

Trades in this filing

Insider Date Transaction Shares Price Value Owned after D/I In the form
Einhorn Irving M. Director 2017-07-06 Grant or award +9,161 $0.59 $5,405 20,114 D
Derivatives
Einhorn Irving M. Director 2017-06-08 Grant or award · Stock Option (right to buy) +5,000 5,000 D
Loading xslF345X03/primary_doc.xml…